FindTrial
Sign In

Comparative the effective concentration of remifentanil through a target-controlled infusion for cesarean section under general anesthesia based on the ideal body weight vs. total body weight

Comparative the effective concentration of remifentanil through a target-controlled infusion for cesarean section under general anesthesia based on the ideal body weight vs. total body weight

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-17010660
Enrollment
Unknown
Registered
2017-02-17
Start date
2017-02-17
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

caesarean section

Interventions

IBW:remifentani administrated through a target-controlled infusion
total body weight :remifentani administrated through a target-controlled infusion

Sponsors

Qilu Hospital of Shangdong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 45 Years

Inclusion criteria

Inclusion criteria: Over 33 gestational weeks, absolute or relative contraindications to regional anesthesia: thrombopenia, spine malformation, and so on.

Exclusion criteria

Exclusion criteria: Exact fetal distress, severe preeclampsia (SBP higher than 180mmHg or DBP higher than 110mmHg), cardiorespiratory diseases, neurological disease, known congeital abnormalities or signs of fetal compromise, and body height shorter than 152cm.

Design outcomes

Primary

MeasureTime frame
bispectral index, BIS;Blood presure;Apgar score;—

Countries

China

Contacts

Public ContactZhang Zhaohang

Qilu Hospital of Shandong University

zzh398@126.com+86 18560083826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026